Stockpickr! Your Source for Stock Ideas

Videos about AMGN

Video	Description	Tags	Date Updated
They Just Don't Get Genentech!	Marek Fuchs shoots to pieces CNBC's report that Genentech's top four drugs underperformed during their good quarter.	AMGN BIIB CELG DNA GE GENZ GILD	April 12, 2008
Biotech Is Back, But Don't Get Burned	Risk has returned to the market, and it's benefiting biotech stocks. Adam Feuerstein, senior writer at TheStreet.com, says the ones to watch are Vertex and BioMarin.	AMGN BMRN DNA GILD IBB ONXX VRTX	April 08, 2008
The Real Stroy Wrap, January 25	Stocks in the U.S. started the session higher Friday, but the major averages slipped into the red and closed with losses as investors lightened up on some of their recent buys ahead of next week's earnings and Federal Reserve meeting.	AMGN CAT GS HON MSFT	January 26, 2008
News You Need: Amgen, Ford	Companies making headlines today include Amgen, Ford and Microsoft.	AMGN ETFC F HSY MSFT NOK PMTC T UNP XRX	January 24, 2008
Why Goldman and Cisco's CEOs Give to Clinton and McCain	Political correspondent John Fout tells Simon Constable which CEOs are donating to the various campaigns.	AMGN CSCO EBAY FDX GS MS NWS	January 11, 2008
Real Story Wrap: December 10, 2007	Stocks in the U.S. finished Monday with gains as the financials and the homebuilders led Wall Street higher a day ahead of the Federal Reserve's last policy meeting of 2007.	AMGN ARXT CELG CFC MBI MLNM MOGN	December 10, 2007
Real Story Wrap: December 7, 2007	Stocks in New York closed little changed Friday as the latest employment report from the government failed to give traders any reason to make big bets ahead of next week's Federal Reserve meeting.	AAPL AMGN AXP GME MVSN SGR TOL	December 08, 2007
Breaking Down Big Biotech: Amgen, Genentech and Gilead	Adam Feuerstein, senior writer for TheStreet.com, breaks down the Biotech HOLDRs into its component parts: Amgen, Genentech and Gilead.	AMGN BBH DNA GILD	September 27, 2007
Fund Manager Says Yes to Intuitive Surgical, No to Amgen	Frank Sustersic, portfolio manager of the Touchstone Healthcare & Biotechnology fund, explains why he is avoiding Amgen and sticking with Intuitive Surgical.	AMGN BAX ISRG SHPGY THBCX	September 04, 2007
Intuitive Surgical's Growth Isn't Over, Says Fund Manager	Joseph Biondo Jr., portfolio manager for the Biondo Growth fund, discusses his top picks, including Intuitive Surgical and Garmin.	AMGN BIONX GRMN ISRG	August 21, 2007